The crucial impact of NIH funding on allergy/immunology patient care and research

Through the innovative work of investigators supported by National Institutes of Health (NIH) funding, the United States is acknowledged as the global leader in biomedical research. This dominance has stretched over 80 years1 and has resulted in an unprecedented number of new therapies that have revolutionized medical practice. The NIH investment in the field of allergy and immunology has produced new biologic therapies and drugs that affect virtually all disorders cared for by allergists and immunologists, providing relief for patients experiencing the very common forms of allergic disease, including asthma, food allergy, and atopic dermatitis.